Breaking News Instant updates and real-time market news.

NOC

Northrop Grumman

$267.03

1.34 (0.50%)

, OA

Orbital ATK

$110.04

1.65 (1.52%)

19:00
09/17/17
09/17
19:00
09/17/17
19:00

Northrop Grumman nears purchase of Orbital ATK, WSJ reports

Northrop Grumman (NOC) is nearing a purchase of Orbital ATK (OA), a deal that could be worth more than $7.5B, according to The Wall Street Journal, citing people familiar with the matter. A deal could be announced as soon as Monday, sources said.Reference Link

NOC

Northrop Grumman

$267.03

1.34 (0.50%)

OA

Orbital ATK

$110.04

1.65 (1.52%)

NOC Northrop Grumman
$267.03

1.34 (0.50%)

09/06/17
STFL
09/06/17
NO CHANGE
STFL
Stifel says United Tech deal strategic, not a sign of M&A 'floodgates opening'
Stifel analyst Joseph DeNardi said one of the only risks he sees to defense stocks' multiples would be a shift in cash deployment strategy from a focus on dividends and buybacks to M&A. However, he views United Technologies' (UTX) planned acquisition of Rockwell Collins (COL) as strategic and largely focused on its desire to regain leverage against Boeing (BA) and Airbus (EADSY) and not indicative of the M&A "floodgates opening" in the defense sector. Other publicly traded companies in the defense space include BAE Systems (BAESY), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
08/08/17
08/08/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), Alphabet (GOOG, GOOGL), and Facebook (FB) were reinstated with a Buy at Mizuho, while eBay (EBAY) and Twitter (TWTR) were reinstated with an Underperform. 2. Broadridge (BR) initiated with a Neutral at DA Davidson. 3. Brighthouse Financial (BHF) initiated with an Overweight at Barclays. 4. Akcea Therapeutics (AKCA) WAS initiated with an Outperform at BMO Capital and Cowen, an Outperform at Wells Fargo, as well as a Buy at Stifel. 5. Lockheed Martin (LMT) and Raytheon (RTN) were initiated with an Overweight at Morgan Stanley, while Northrop Grumman (NOC) was initiated with an Equal Weight, and General Dynamics (GD) was initiated with an Underweight at the firm. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/08/17
MSCO
08/08/17
INITIATION
Target $279
MSCO
Equal Weight
Northrop Grumman initiated with an Equal Weight at Morgan Stanley
Morgan Stanley analyst Rajeev Lalwani initiated Northrop Grumman with an Equal Weight and a $279 price target saying its leading revenue profile is offset by light free cash flow yields and margin growth.
05/10/17
VERT
05/10/17
UPGRADE
VERT
Buy
Northrop Grumman upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Robert Stallard upgraded Northrop Grumman to Buy from Hold with a $270 price target telling investors defense sector fundamentals remain positive and share underperformance versus peers provides a buying opportunity.
OA Orbital ATK
$110.04

1.65 (1.52%)

08/14/17
08/14/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. International Paper (IP) upgraded to Buy from Neutral at DA Davidson with analyst Steven Chercover citing the 18% upside to his price target of $62 as well as the 3.5% dividend yield. 2. Masimo (MASI) upgraded to Buy from Neutral with analyst Sean Lavin saying he is more bullish on the Philips (PHG) agreement leading to increased revenue and margins, and the recent share pullback has provided a buying opportunity. Further, the analyst thinks Johnson & Johnson (JNJ) could be an acquirer of Masimo as it sells its products into the OR and ICU markets and would "massively" expand operating margins, and notes Philips may see the value of Masimo's products and make a bid. 3. NetApp (NTAP) upgraded to Buy from Hold at Maxim with analyst Nehal Chokshi saying channel checks indicate the company's hybrid cloud capabilities have gained traction. 4. Orbital ATK (OA) upgraded to Buy from Hold at Argus with analyst David Coleman citing valuation and his belief that its cash flow can increase. 5. Werner (WERN) upgraded to Overweight from Equal Weight at Stephens with analyst Brad Delco saying it is an attractive way to play an inflection in TL fundamentals. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/14/17
ARGS
08/14/17
UPGRADE
ARGS
Buy
Orbital ATK upgraded on valuation cash flow outlook at Argus
As noted earlier, Argus upgraded Orbital ATK to Buy from Hold. Analyst David Coleman upgraded the stock based on valuation and his belief that its cash flow can increase. He notes that the company expects its results to accelerate in 2H17 and expects to hit milestones in 2H17 that will boost its cash flow. Coleman believes that the company will benefit from increased U.S. defense spending in 2017-2018. Target $120.
08/14/17
ARGS
08/14/17
UPGRADE
ARGS
Buy
Orbital ATK upgraded to Buy from Hold at Argus
06/05/17
GSCO
06/05/17
INITIATION
Target $106
GSCO
Neutral
Orbital ATK reinstated with a Neutral at Goldman Sachs
Goldman analyst Noah Poponak reinstated Oribtial ATK with a Neutral and a $106 price target saying medium-term fundamental inputs are balanced and valuation is not overly compelling.

TODAY'S FREE FLY STORIES

VST

Vistra Energy

$23.92

0.28 (1.18%)

07:45
12/12/18
12/12
07:45
12/12/18
07:45
Recommendations
Vistra Energy analyst commentary  »

Vistra Energy shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABIL

Ability

$2.37

0.005 (0.21%)

07:45
12/12/18
12/12
07:45
12/12/18
07:45
Hot Stocks
Ability regains Nasdaq compliance »

Ability announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$15.45

0.02 (0.13%)

07:44
12/12/18
12/12
07:44
12/12/18
07:44
Recommendations
Array BioPharma analyst commentary  »

Array BioPharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$18.02

0.02 (0.11%)

07:44
12/12/18
12/12
07:44
12/12/18
07:44
Initiation
iQIYI initiated  »

iQIYI initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THS

TreeHouse

$51.64

2.69 (5.50%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Recommendations
TreeHouse analyst commentary  »

TreeHouse price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$2.78

0.07 (2.58%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Hot Stocks
KemPharm presents research on IV abuse potential of SDX at ACNP »

KemPharm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCCO

Southern Copper

$32.17

-0.08 (-0.25%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Downgrade
Southern Copper rating change  »

Southern Copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THS

TreeHouse

$51.64

2.69 (5.50%)

07:43
12/12/18
12/12
07:43
12/12/18
07:43
Recommendations
TreeHouse analyst commentary  »

TreeHouse price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASR

Asur

$141.69

-0.66 (-0.46%)

07:42
12/12/18
12/12
07:42
12/12/18
07:42
Upgrade
Asur rating change  »

Asur upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$142.07

0.2 (0.14%)

, GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

07:42
12/12/18
12/12
07:42
12/12/18
07:42
Recommendations
Facebook, Alphabet Class A analyst commentary  »

Facebook testing search…

FB

Facebook

$142.07

0.2 (0.14%)

GOOGL

Alphabet Class A

$1,061.32

8.52 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTM

Constellium

$8.12

0.2 (2.53%)

07:40
12/12/18
12/12
07:40
12/12/18
07:40
Conference/Events
Constellium to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 18

    Dec

ZLAB

Zai Lab

$19.93

-0.01 (-0.05%)

07:39
12/12/18
12/12
07:39
12/12/18
07:39
Hot Stocks
Zai Lab announces acceptance of Zejula NDA submission by NMPA »

Zai Lab announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$114.69

1.8 (1.59%)

07:39
12/12/18
12/12
07:39
12/12/18
07:39
Recommendations
Madrigal Pharmaceuticals analyst commentary  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHAK

Shake Shack

$46.73

-0.85 (-1.79%)

07:38
12/12/18
12/12
07:38
12/12/18
07:38
Recommendations
Shake Shack analyst commentary  »

Shake Shack price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

AEO

American Eagle

$19.03

-0.49 (-2.51%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Recommendations
American Eagle analyst commentary  »

American Eagle shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$110.04

-0.78 (-0.70%)

07:36
12/12/18
12/12
07:36
12/12/18
07:36
Downgrade
Marriott rating change  »

Marriott downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.26

-0.04 (-3.08%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Hot Stocks
MYnd Analytics appoints Patrick Herguth CEO, George Carpenter CIO »

MYnd Analytics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$24.58

-0.17 (-0.69%)

, T

AT&T

$29.70

-0.21 (-0.70%)

07:35
12/12/18
12/12
07:35
12/12/18
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$24.58

-0.17 (-0.69%)

T

AT&T

$29.70

-0.21 (-0.70%)

NIO

NIO Inc.

$7.05

0.03 (0.43%)

BX

Blackstone

$30.50

0.03 (0.10%)

KHC

Kraft Heinz

$48.38

0.1 (0.21%)

NBR

Nabors Industries

$2.82

0.12 (4.44%)

KKR

KKR

$20.92

-0.21 (-0.99%)

TROX

Tronox

$7.11

0.06 (0.85%)

MLCO

Melco Resorts & Entertainment

$17.36

0.35 (2.06%)

DLPH

Delphi Technologies

$16.07

0.26 (1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 18

    Dec

  • 30

    Jan

  • 12

    Feb

  • 20

    Mar

07:35
12/12/18
12/12
07:35
12/12/18
07:35
General news
U.S. MBA mortgage market index rose 1.6% »

U.S. MBA mortgage market…

AUDVF

Audi AG

$0.00

(0.00%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Audi names interim CEO Bram Schot as chairman of the board »

The Supervisory Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTB

Cooper Tire

$30.71

0.12 (0.39%)

07:34
12/12/18
12/12
07:34
12/12/18
07:34
Hot Stocks
Cooper Tire, Sailun announce JV for new TBR tire plant in Vietnam »

Cooper Tire & Rubber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDS

Aridis Pharmaceuticals

$7.96

0.02 (0.25%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Aridis Pharmaceuticals enrolls first subject in Phase 1/2a lung infection trial »

Aridis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$85.72

-0.14 (-0.16%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Hot Stocks
Neurocrine says valbenazine did not meet primary endpoint in Phase IIb study »

Neurocrine Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$66.30

0.58 (0.88%)

07:32
12/12/18
12/12
07:32
12/12/18
07:32
Upgrade
Realty Income rating change  »

Realty Income upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$33.95

1.285 (3.93%)

07:31
12/12/18
12/12
07:31
12/12/18
07:31
Conference/Events
Health Insurance Innovations to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.